CONSOLIDATED FINANCIAL STATEMENTS AND OTHER INFORMATION INDIANA UNIVERSITY HEALTH, INC. AND SUBSIDIARIES AS OF SEPTEMBER 30, 2018 AND DECEMBER 31,

CONSOLIDATED FINANCIAL STATEMENTS AND OTHER INFORMATION INDIANA UNIVERSITY HEALTH, INC. AND SUBSIDIARIES AS OF SEPTEMBER 30, 2018 AND DECEMBER 31, 2017 AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017

TABLE OF CONTENTS Management s Discussion of Financial Performance 1 Page Consolidated Financial Statements Consolidated Balance Sheets 11 Consolidated Statements of Operations and Changes in Net Assets 13 Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements 15 16 Other Information Special Purpose Combined Balance Sheets Obligated Group and 39 Designated Affiliates Special Purpose Combined Statements of Operations Obligated 41 Group and Designated Affiliates Special Purpose Combined Balance Sheets Obligated Group 42 Special Purpose Combined Statements of Operations Obligated 44 Group Statistical and Other Data 45

MANAGEMENT S DISCUSSION OF FINANCIAL PERFORMANCE

Management s Discussion of Financial Performance The financial statement information and other data as of September 30, 2018 and December 31, 2017 and for the nine months ended are derived from the unaudited consolidated financial statements and other records of Indiana University Health, Inc. (Indiana University Health) and subsidiaries (collectively referred to herein as the Indiana University Health System). The consolidated financial statements include all adjustments, consisting of normal recurring and other accruals, which management of the Indiana University Health System considers necessary for a fair presentation of financial position, results of operations and changes in net assets, and cash flows for these periods in conformity with U.S. generally accepted accounting principles (GAAP). The financial data relating to the Obligated Group and the Obligated Group and Designated Affiliates, as defined in the Indiana University Health Obligated Group Master Trust Indenture, as amended, is provided as supplementary information. The accompanying financial statement information should be read in conjunction with the audited consolidated financial statements and the notes thereto of Indiana University Health and subsidiaries as of and for the years ended December 31, 2017 and 2016 (not included herein). Nature of Operations The principal operating activities of the Indiana University Health System are conducted at owned facilities or majority-owned or controlled subsidiaries and consist of the following: Downtown Hospitals of the Academic Health Center Consist of three acute, tertiary, quaternary care, and diagnostic facilities, licensed as a single hospital, which constitutes the principal hospital activities of the academic health center and whose operations are located in the downtown area of Indianapolis, Indiana. These three hospitals, Methodist Hospital, University Hospital, and Riley Hospital, are located on or near the campus of Indiana University-Purdue University Indianapolis and the Indiana University School of Medicine (the School of Medicine). Central Indiana Facilities Consist of three acute care hospitals, a critical access hospital, and an acute care rehabilitation hospital located in the western and northern suburban areas of metropolitan Indianapolis, Indiana. Principal hospital subsidiaries include Indiana University Health North Hospital, Inc. (North), Indiana University Health West Hospital, Inc. (West), Indiana University Health Saxony Hospital (Saxony), Indiana University Health Tipton Hospital, Inc. (Tipton), and Rehabilitation Hospital of Indiana, Inc. (RHI). 1

Statewide Facilities Consist of acute care hospitals and health care systems located in Lafayette, Monticello, Frankfort, Muncie, Hartford City, Portland, Bedford, Paoli, and Bloomington, Indiana. Principal hospital subsidiaries include Indiana University Health Arnett, Inc. (Arnett), Indiana University Health White Memorial Hospital, Inc. (White), Indiana University Health Frankfort Hospital, Inc. (Frankfort), Indiana University Health Ball Memorial Hospital, Inc. and subsidiaries (Ball Memorial) including Indiana University Health Blackford Hospital, Inc. (Blackford), Indiana University Health Jay, Inc. (Jay), Indiana University Health Bedford, Inc. (Bedford), Indiana University Health Paoli, Inc. (Paoli), and Indiana University Health Bloomington, Inc. and subsidiaries (Bloomington). Physician Operations Consist of physician offices and physician-group practices and clinics. Principal subsidiaries or divisions include Indiana University Health Physicians (IUHP), a nonprofit organization with locations primarily in Indianapolis, Indiana, Indiana University Health Arnett Physicians, Indiana University Health Ball Memorial Physicians, Inc., Indiana University Health Southern Indiana Physicians, Inc., and Indiana University Health Fort Wayne Physicians. Ambulatory Care Consists of personal and home health care services, occupational health services, outpatient oncology services, outpatient surgery centers, and urgent care centers that are located throughout the State of Indiana. Principal subsidiaries or divisions include Indiana University Health Home Care, Indiana University Health Occupational Health Centers, Workplace Health Services, Indiana University Health Central Indiana Cancer Centers, Indiana University Health Morgan, several surgery center joint ventures, and an urgent care center joint venture. Medical Risk Consists of the medical management of health care services of members whose health care coverage is provided by the managed care networks of the Indiana University Health System. Includes health maintenance organizations and other insurance related organizations that provide health plan services to fully-insured and self-insured members residing in Indiana. Insurance offerings include commercial group products (fully-insured and self-insured), Medicare Advantage products, and Medicaid management services. The Indiana University Health System also participates in the medical management of Medicare fee-for-service members through a NextGen Accountable Care Organization contract with the Centers for Medicare and Medicaid (CMS). The Indiana University Health System no longer provides products on the Health Insurance Marketplace (Exchange) as of January 1, 2018. Foundations Indiana University Health is the sole corporate member of Indiana University Health Foundation, Inc. (Indiana University Health Foundation), formerly known as Methodist Health Foundation, Inc., which aids and supports Methodist Hospital and other programs and areas of Indiana University Health. On December 31, 2017, Tipton County Health Care Foundation, Inc. (Tipton Foundation), Indiana University Health Arnett Hospital Foundation, Inc. (Arnett Foundation) and Indiana University Health Paoli Hospital Foundation, Inc. (Paoli Foundation) were merged into the Indiana University Health Foundation. Prior to December 31, 2017, Tipton was the sole corporate member of Tipton Foundation, which aids in carrying out the mission of Tipton; Arnett was the sole corporate member of Arnett Foundation, which aids and 2

supports Arnett; and the corporate members of Paoli Foundation, which aids and supports Paoli, were Paoli, Bloomington, and the Board of Commissioners of Orange County, Indiana. On September 30, 2018, Indiana University Health Jay Hospital Foundation, Inc. (Jay Foundation) was merged into the Indiana University Health Foundation. Jay was the sole corporate member of Jay Foundation, which aids in carrying out the mission of Jay. Those foundations will continue to serve the same purposes as prior to the mergers. Ball Memorial is the sole corporate member of Indiana University Health Ball Memorial Hospital Foundation, Inc. (BMH Foundation), which aids in carrying out the mission of Ball Memorial and Blackford. RHI is the sole corporate member of RHI Foundation, Inc. (RHI Foundation), which aids and supports RHI. Consolidated Statement of Operations and Changes in Net Assets (Compared to September 30, 2017) Revenue. Total operating revenue of $4,704,226 for the nine months ended September 30, 2018 increased 2.0%, or $90,695 compared to the nine months ended September 30, 2017 $4,613,531. Patient service revenue, when excluding increased reimbursement related to the Medicaid Assessment Fee program, upper payment limit reimbursement (UPL), and state disproportionate share revenue (DSH), increased by $196,494 or 5.3% for the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. The increase reflects the impact of recent strategic transactions, annual rate increases as well as increased inpatient volumes (see below). The table below shows discharges and surgery cases by division. Year over Year 9/30/2018 9/30/2017 Variance Percentage Inpatient Discharges Consolidated 88,544 85,483 3,061 3.6% Downtown 37,781 37,163 618 1.7% Statewide 35,371 32,956 2,415 7.3% Central 15,392 15,364 28 0.2% Total Surgery Cases Consolidated 80,975 80,863 112 0.1% Downtown 25,438 25,800 (362) -1.4% Statewide 18,923 18,666 257 1.4% Central 10,114 10,343 (229) -2.2% Ambulatory 26,500 26,054 446 1.7% During 2012, the Indiana General Assembly approved a hospital assessment fee program (Medicaid Assessment Fee). Under this program, the Office of Medicaid Policy and Planning (OMPP) collects a fee from eligible hospitals. The fee is used in part to 3

increase reimbursement to eligible hospitals for services provided in both fee-for-service and managed care programs, and as the state share of DSH payments. The program was effective retroactively from July 1, 2011, through June 30, 2013, and was subsequently extended through June 30, 2019. For the nine months ended September 30, 2018, increased reimbursement related to the Medicaid Assessment Fee program totaled $307,680. For the nine months ended September 30, 2017, increased reimbursement related to the Medicaid Assessment Fee program totaled $209,080. The Indiana University Health System qualifies for supplemental Medicaid payments through the UPL program under Indiana law. The UPL program was established to pay qualifying providers the difference between what Medicare would have paid and what Medicaid actually paid. As of September 30, 2018, $37,205 of UPL revenue was recognized compared to $68,003 as of September 30, 2017. Certain hospitals of the Indiana University Health System are Medicaid DSH providers under Indiana law and, as such, are eligible to receive state DSH payments. The amount of these additional state DSH funds is dependent on regulatory approval by agencies of the federal and state governments and is determined by the level, extent, and cost of uncompensated care (as defined) and various other factors. No DSH revenue was received for the nine months ended September 30, 2018. In the nine months ended September 30, 2017, $30,346 of DSH revenue was received. Based upon final rule by the Centers for Medicare and Medicaid Services, net of reserves totaling ($18,346) and ($15,095), related to the state fiscal years ended June 30, 2017 and 2016, respectively, were recognized against the DSH revenue received, netting ($3,095) of DSH revenue recognized in 2017. The amount of state DSH and UPL funds vary by year and the amount to be received in future periods cannot be guaranteed. Member premium revenue aggregated $254,871 for the nine months ended September 30, 2018 and $434,010 for the prior year. The decrease in member premium revenue is mainly related to not offering products on the Exchange in 2018. Other operating revenue of $175,775 for the nine months ended September 30, 2018 was comparable to the nine months ended September 30, 2017, $173,332. Expenses. Total operating expenses of $4,310,058 increased by 1.0%, or $41,113 compared to the nine months ended September 30, 2017, $4,268,945. Salaries, wages, and benefits increased 5.9%, or $127,502, to $2,289,083 compared to the nine months ended September 30, 2017. The increase is primarily a result of base pay increases effective mid-2017 and 2018, as well as an increase in full time equivalent employees (FTEs). The average number of FTEs was 29,863 and 28,686 for the nine months ended, respectively. Supplies, drugs, purchased services, and other expenses of $1,530,022 increased 5.8%, or $83,731, compared to the nine months ended September 30, 2017, $1,446,291. The increase was primarily driven by increases in supplies expense due to inpatient volumes and continued increases in pharmaceutical expenses. 4

Fees related to the Medicaid Assessment Fee program were $109,472 for the nine months ended September 30, 2018, compared to $97,815 in the same period in the prior year. Health claims to providers expenses of $173,425 decreased by 52.6%, or $192,344, compared to the nine months ended September 30, 2017, $365,769. The decrease in claims expense is mainly related to not offering Exchange products in 2018. Depreciation and amortization expense of $176,341 increased 2.6%, or $4,449, from the same period in the prior year of $171,892. Interest expense of $31,715 increased by 23.9%, or $6,118, compared to the same period in the prior year, $25,597, mainly due to an increase in the balance of debt outstanding, a higher proportion of underlying fixed-rate debt, and rising short-term interest rates in the market. Investment income amounted to $122,136 for the nine months ended September 30, 2018, including $75,752 of interest and dividend income, $928 of unrealized losses on investments, and $47,312 of realized gains on investments, net of fees. For the nine months ended September 30, 2017, investment income aggregated to $355,597, which included $57,944 of interest and dividend income, $276,554 of unrealized gains on investments, and $21,099 of realized gains on investments, net of fees. Gains (losses) on interest rate swaps aggregated $19,324 and ($1,105) for the nine months ended September 30, 2018, and 2017, respectively. Consolidated Balance Sheet (Compared to December 31, 2017) Consolidated Financial Position. Total cash and investments (which principally consist of cash and cash equivalents, short-term investments, current portion of assets limited as to use, board-designated funds and other investments, and donor-restricted funds) amounted to $6,092,035 at September 30, 2018, and $5,443,259 at December 31, 2017. The number of days cash and investments on hand, excluding donor-restricted funds, trustee-held funds and funds held by insurance captives, was 389 days at September 30, 2018 and 350 days as of December 31, 2017. The number of days revenue in receivables (excluding the increased reimbursement under the Medicaid Assessment Fee program and related receivable) was 52 days at September 30, 2018, and 62 days at December 31, 2017. The number of days expenses in accounts payable, accrued expenses, and certain other current liabilities (excluding fees associated with the Medicaid Assessment Fee program and related liability) was 56 days at both September 30, 2018 and December 31, 2017. Net current assets, or working capital, increased 25.8% to $776,838 at September 30, 2018 compared to $617,365 at December 31, 2017 primarily due to the repayment of the drawn balance on the lines of credit with new debt proceeds from the issuance of the Series 2018A bonds as well as an increase in current portion of assets limited as to use in the current year. Net property and equipment of $2,319,690 decreased $19,707 from December 31, 2017 due to continuing depreciation, partially offset by capital purchases. Firm commitments for construction-in-progress totaled $140,813 at September 30, 2018. 5

Indiana University Health Obligated Group has executed direct-pay letter-of-credit agreements in support of all of its publicly remarketed variable-rate bond series, which require the credit provider to purchase bonds in the event the bonds are not remarketed. In addition, it has executed direct purchase agreements, whereby the credit provider purchases bonds for a predetermined period of time, after which the agreement must be extended or the bonds must be remarketed or reissued. In each of these two instances, the bonds have a longer nominal maturity than the agreement, but the existence and terms of these agreements allow for the long-term classification of the associated variable-rate bond series. On April 17, 2018, Indiana University Health issued $354,000 in par value of Series 2018A taxable, fixed-rate bonds. A portion of the proceeds was used to advance refund $60,500 in par amount of the Indiana Finance Authority Hospital Revenue Bonds, Series 2011N (Indiana University Health Obligated Group), to refinance all of the Indiana Finance Authority Hospital Revenue Bonds, Series 2015C (Indiana University Health Obligated Group) in the amount of $50,000, and to repay the balance on Indiana University Health s revolving commercial bank line of credit in the amount of $50,000. Another portion of the proceeds was used to finance the termination payments related to certain interest rate swaps (see Notes to Consolidated Financial Statements Note 6). Remaining proceeds have been or will be used for general corporate purposes. On October 12, 2017, through the Indiana Finance Authority, Indiana University Health amended its Series 2011H and 2011I tax exempt, variable-rate, direct-purchase bonds changing both the variable rate and principal repayment schedule. Indiana University Health sold the bonds to a new direct purchaser with the expiration date of the direct-purchase agreement being the same date as the final maturity of the bonds. As of September 30, 2018 and December 31, 2017, the Indiana University Health System maintained several lines of credit totaling $230,000 and $105,000, respectively. As of September 30, 2018 no amounts are drawn on the lines of credit. As of December 31, 2017, the total balance drawn on the lines of credit was $50,000, which was included in the current portion of long-term debt as the line of credit associated with the drawn balance had an expiration date of June 30, 2018. The balance on the line was repaid in April 2018, in conjunction with the issuance of the Series 2018A bonds. Unrestricted net assets, or equity, amounted to $7,073,648 at September 30, 2018 and $6,594,120 at December 31, 2017 and includes the net unrealized losses on swaps of $38,382 and $75,813 at September 30, 2018 and December 31, 2017, respectively. Strategic Initiatives As part of its commitment to being a leader in both the treatment of patients with complex illnesses as well as in the transition from payment models that reward volume to those that reward value, the Indiana University Health System continuously evaluates its operations with goals to achieve superior clinical outcomes and to treat patients in the most beneficial and least resource-intensive settings possible as it works to effectively manage the health of populations. 6

As part of this continual evaluation, management engages in discussions at times with unaffiliated third parties regarding potential affiliations, acquisitions, dispositions, divestitures, joint ventures, and other transactions. In addition, management considers the potential to change the services offered at a given facility or consolidate and/or eliminate redundant services. Such changes could be material, impacting the future composition of the system. In October 2017, Indiana University Health announced plans to open a pediatric specialty care office as well as a primary care office in Fort Wayne, Indiana in 2018. The pediatric specialty care office opened in January 2018 and the primary care office opened August 1, 2018. The office openings are in response to the Fort Wayne community s growing need for primary care, to attract and retain quality physicians in the area, and to continue efforts to make Indiana a healthier state overall. Capital Expenditures In December 2017, the Indiana University Health Board of Directors approved a capital expenditure plan to integrate maternity and neonatal services at Riley Hospital. When finished, Riley Hospital will be able to accommodate more than 3,800 deliveries annually (up from approximately 3,200), including those from high risk mothers, and provide care for babies with known congenital anomalies. Also in December 2017, the Indiana University Health Board of Directors approved a capital expenditure plan to build a cancer care facility at North. The plan is to build an approximately 88,000 square foot, two-story patient experience-focused facility that will provide full service cancer treatment options and necessary support services. In October 2017, the Indiana University Health Board of Directors approved a capital expenditure plan to build a regional health campus in Bloomington, Indiana, which will increase Bloomington s ability to improve patient care by providing more opportunities for collaboration among clinical, research, and medical staff and faculty. This plan will allow the Indiana University School of Medicine to expand its medical education programs and research opportunities on the Bloomington campus. As part of this plan, Bloomington will build a replacement hospital, which will further its mission of providing cutting-edge health services to the region. Also in October 2017, the Indiana University Health Board of Directors approved a capital expenditure plan for expansion at West. The expansion is expected to include approximately 48 additional inpatient beds, a new operating room, and additional support services space to accommodate rising patient volumes. In April 2015, the Indiana University Health Board of Directors approved a plan to consolidate downtown Indianapolis adult services to one medical campus centered on Capitol Avenue and 16th Street (the current site of Methodist Hospital). As Indiana University Health is committed to improving the health of its patients and communities, the plan also includes the development of an array of ambulatory care services for residents of the neighborhoods around the downtown Indianapolis campus. The adult service medical campus is expected to include a medical education building and faculty offices on- 7

site to enhance ongoing collaboration with the Indiana University School of Medicine and support the tripartite mission of clinical care, research, and education. While the Board has authorized certain preliminary activities, including strategic planning and analysis related to this plan, it has not approved the scope of this project or total capital expenditures related thereto. Certain statements are forward-looking statements that are based on the beliefs of, and assumptions made by, the management of Indiana University Health. Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the performance of the Indiana University Health System to be materially different from any expected future performance. Strategic Transactions Indiana University Health held 50% membership interests in both MDwise, Inc. and MDwise Medicaid Network, Inc., with Health and Hospital Corporation of Marion County (HHC) holding the other 50% membership interest. On October 31, 2017, a sponsorship transfer agreement was entered into with Michigan-based McLaren Health Care (McLaren), whereby Indiana University Health and HHC would transfer their membership interests in MDwise, Inc. and MDwise Medicaid Network, Inc. to McLaren. The transaction closed on December 29, 2017, and resulted in the recognition of a gain of $68,152 in other revenue on the consolidated statement of operations and changes in net assets. On November 20, 2017, Indiana University Health entered into an Affiliation and Asset Transfer Agreement with Jay County Hospital, a 25-bed critical access hospital located in Portland, Indiana. Effective March 1, 2018, Jay County Hospital transferred substantially all of its assets and liabilities to Indiana University Health Jay, Inc., a newly created nonprofit organization, and Indiana University Health became the sole corporate member. Indiana University Health recognized the assets acquired and the liabilities assumed, measured at their fair values as of the date of acquisition, and recognized an inherent contribution as a result of the transaction in the amount of $31,920. On June 1, 2017, Indiana University Health sold two outpatient hemodialysis incenter units in downtown Indianapolis and a home dialysis program to ISD Renal, Inc., a subsidiary of DaVita, Inc. Through the sale transaction, Indiana University Health sold substantially all of the assets owned and used by the dialysis business for $25,763. Indiana University Health recognized a gain of $25,285 related to the transaction. On November 10, 2016, Indiana University Health entered into a lease agreement with Clinton County to lease the hospital building and other related property and equipment and to assume the operations of Frankfort Hospital, the Clinton County-owned hospital, effective June 1, 2017. As of the effective date, Indiana University Health began a five-year lease with renewal options for the 25-bed county-owned critical access hospital and affiliated medical offices. The annual minimum rental rate is $1,000. Additional rent can be triggered if the hospital reaches certain net income targets, which is not expected to occur in 2018. 8

In 2015, a Contribution and Sale Agreement (Agreement) was executed by and among Indiana University Health, Indiana University Health La Porte (La Porte), Frankfort Health Partner, Inc. and Community Health Systems, Inc. (CHS) and other affiliated entities. In anticipation of the Agreement, Indiana University Health and La Porte formed a limited liability company, La Porte Health System, LLC (La Porte Health System) with Indiana University Health holding a 20% interest and La Porte holding 80%. At closing, Frankfort Health Partner, Inc., a subsidiary of CHS, purchased La Porte s 80% interest in the La Porte Health System. The Agreement included a put option for Indiana University Health to put its interest in La Porte Health System to CHS at its sole discretion. In August 2017, Indiana University Health executed the Notice of Exercise of Put Option as outlined in the limited liability company agreement, and in March 2018, an appraisal process was agreed to by the equity partners. Effective August 10, 2018, Indiana University Health executed a Unit Purchase Agreement, effectuating the sale of Indiana University Health s remaining 20% investment in La Porte Health System to Frankfort Health Partner, Inc. 9

Adjusted Operating Income The following table adjusts operating income for significant one-time transactions or significant items that relate to prior years. Management uses these measures internally for planning, forecasting, and evaluating the performance of the Indiana University Health System. The table also removes operating income attributable to noncontrolling interests, which primarily relates to ambulatory surgery centers in which third parties hold significant noncontrolling interests. Internally, management reviews operating results after allocation to noncontrolling interests, in part, because a significant portion of the operating results of these entities is distributed to the noncontrolling interest holders each period. Non-GAAP measures should be considered in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. For additional information on the programs that resulted in these adjustments and on noncontrolling interests refer to the consolidated financial statements and the notes thereto of Indiana University Health and subsidiaries for the nine months ended September 30, 2018 and 2017. Adjusted Operating Income Nine Months Ended September 30 2018 2017 Operating income as reported $ 394,168 $ 344,586 Noncontrolling interests in subsidiaries (98,224) (82,749) DSH - 15,095 Gain on sale of dialysis business - (25,285) Operating income adjusted $ 295,944 $ 251,647 Operating margin adjusted 6.5% 5.7% During 2017, reserves were recorded on DSH revenue related to the state fiscal year ended 2016. During 2017, Indiana University Health sold its dialysis business (see Strategic Transactions). 10

CONSOLIDATED FINANCIAL STATEMENTS

Indiana University Health, Inc. and Subsidiaries Consolidated Balance Sheets September 30 December 31 2018 2017 Assets (Unaudited) (Audited) Current assets: Cash and cash equivalents $ 385,881 $ 414,674 Short-term investments 86,865 5,081 Current portion of assets limited as to use 188,890 143,611 Patient accounts receivable 871,354 870,252 Other receivables 166,825 156,281 Prepaid expenses 53,548 46,026 Inventories 99,770 85,856 Total current assets 1,853,133 1,721,781 Assets limited as to use: Board-designated investment funds and other investments 5,340,771 4,791,654 Donor-restricted investment funds 89,628 88,239 Total assets limited as to use, less current portion 5,430,399 4,879,893 Property and equipment: Cost of property and equipment in service 5,628,151 5,536,733 Less accumulated depreciation (3,386,066) (3,267,111) 2,242,085 2,269,622 Construction-in-progress 77,605 69,775 Total property and equipment, net 2,319,690 2,339,397 Other assets: Equity interest in unconsolidated subsidiaries 20,619 44,103 Interest in net assets of foundations 22,621 22,038 Goodwill, intangibles, and other assets 313,554 341,810 Total other assets 356,794 407,951 Total assets $ 9,960,016 $ 9,349,022 Continued on next page. 11

Indiana University Health, Inc. and Subsidiaries Consolidated Balance Sheets (continued) September 30 December 31 2018 2017 Liabilities and net assets (Unaudited) (Audited) Current liabilities: Accounts payable and accrued expenses $ 535,240 $ 525,199 Accrued salaries, wages, and related liabilities 311,204 296,053 Accrued health claims 76,181 95,844 Estimated third-party payer allowances 99,103 87,215 Current portion of long-term debt 54,567 100,105 Total current liabilities 1,076,295 1,104,416 Noncurrent liabilities: Long-term debt, less current portion 1,545,514 1,351,115 Interest rate swaps 38,382 75,813 Accrued pension obligations 11,276 10,134 Accrued medical malpractice claims 65,129 63,626 Other 34,075 33,876 Total noncurrent liabilities 1,694,376 1,534,564 Total liabilities 2,770,671 2,638,980 Net assets: Indiana University Health 6,837,362 6,368,314 Noncontrolling interest in subsidiaries 236,286 225,806 Total unrestricted 7,073,648 6,594,120 Temporarily restricted 44,180 42,004 Permanently restricted 71,517 73,918 Total net assets 7,189,345 6,710,042 Total liabilities and net assets $ 9,960,016 $ 9,349,022 12

Nine Months Ended Three Months Ended September 30 September 30 2018 2017 2018 2017 (Unaudited) (Unaudited) Revenues: Patient service revenue $ 4,273,580 $ 4,006,189 $ 1,454,830 1,425,160 Member premium revenue 254,871 434,010 83,585 142,937 Other revenue 175,775 173,332 60,466 58,849 Total operating revenues 4,704,226 4,613,531 1,598,881 1,626,946 Expenses: Salaries, wages, and benefits 2,289,083 2,161,581 786,405 743,343 Supplies, drugs, purchased services, and other 1,530,022 1,446,291 529,635 507,141 e Hospital assessment fee 109,472 97,815 41,841 36,588 Health claims to providers 173,425 365,769 55,313 116,348 Depreciation and amortization 176,341 171,892 59,127 58,403 Interest 31,715 25,597 11,470 8,701 Total operating expenses 4,310,058 4,268,945 1,483,791 1,470,524 f Operating income 394,168 344,586 115,090 156,422 Nonoperating income: Investment income, net 122,136 355,597 78,940 132,936 Gains (losses) on interest rate swaps, net 19,324 (1,105) 4,180 (54) Inherent contribution of acquired entity 31,920-60 - Debt extinguishment and other (1,855) 2,093 (880) 2,088 Total nonoperating income 171,525 356,585 82,300 134,970 Consolidated excess of revenues over expenses 565,693 701,171 197,390 291,392 Less amounts attributable to noncontrolling interest in subsidiaries 98,224 82,749 30,205 29,104 Excess of revenues over expenses attributable to Indiana University Health and subsidiaries 467,469 618,422 167,185 262,288 Continued on next page. Indiana University Health, Inc. and Subsidiaries Consolidated Statements of Operations and Changes in Net Assets 13

Indiana University Health, Inc. and Subsidiaries Consolidated Statements of Operations and Changes in Net Assets (continued) Nine Months Ended Nine Months Ended September 30 September 30 2018 2017 (Unaudited) (Unaudited) Unrestricted net assets: Total Controlling Noncontrolling Total Controlling Noncontrolling Consolidated excess of revenues over expenses $ 565,693 $ 467,469 $ 98,224 $ 701,171 $ 618,422 $ 82,749 Contributions for capital expenditures 833 833 1,665 1,665 Distributions to noncontrolling interests (88,155) (88,155) (94,926) (94,926) Contributions from noncontrolling interests 411 411 Other 746 746 (15,860) (17,069) 1,209 479,528 469,048 10,480 592,050 603,018 (10,968) Temporarily restricted net assets: Change in beneficial interest in net assets of foundations 860 860 Contributions 1,190 1,190 3,293 3,293 Investment return 1,281 1,281 1,346 1,346 Net assets released from restrictions (1,471) (1,471) (1,086) (1,086) Other 316 316 14,645 14,645 2,176 2,176 18,198 18,198 Permanently restricted net assets: Change in beneficial interest in net assets of foundations (269) (269) 8 8 Contributions and other 711 711 5,106 5,106 Beneficial interest reclassification 852 852 Other (2,843) (2,843) (2,401) (2,401) 5,966 5,966 Increase (decrease) in net assets 479,303 468,823 10,480 616,214 627,182 (10,968) Net assets at beginning of period 6,710,042 6,484,236 225,806 5,682,804 5,473,347 209,457 Net assets at end of period $ 7,189,345 $ 6,953,059 $ 236,286 $ 6,299,018 $ 6,100,529 $ 198,489 Three Months Ended Three Months Ended September 30 September 30 2018 2017 (Unaudited) (Unaudited) Unrestricted net assets: Total Controlling Noncontrolling Total Controlling Noncontrolling Consolidated excess of revenues over expenses $ 197,390 $ 167,185 $ 30,205 $ 291,392 $ 262,288 $ 29,104 Contributions for capital expenditures 25 25 Distributions to noncontrolling interests (31,144) (31,144) (30,624) (30,624) Contributions from noncontrolling interests (159) (159) Other 188 188 828 (112) 940 166,275 167,373 (1,098) 261,621 262,201 (580) Temporarily restricted net assets: Change in beneficial interest in net assets of foundations 166 166 Contributions 507 507 2,379 2,379 Investment return 1,280 1,280 246 246 Net assets released from restrictions (518) (518) (92) (92) Other (152) (152) 909 909 1,283 1,283 3,442 3,442 Permanently restricted net assets: Contributions and other 563 563 5,133 5,133 563 563 5,133 5,133 Increase (decrease) in net assets 168,121 169,219 (1,098) 270,196 270,776 (580) Net assets at beginning of period 7,021,224 6,783,840 237,384 6,028,822 5,829,753 199,069 Net assets at end of period $ 7,189,345 $ 6,953,059 $ 236,286 $ 6,299,018 $ 6,100,529 $ 198,489 14

Indiana University Health, Inc. and Subsidiaries Consolidated Statements of Cash Flows Nine Months Ended Three Months Ended September 30 September 30 2018 2017 2018 2017 (Unaudited) (Unaudited) Operating activities Increase in net assets $ 479,303 $ 616,214 $ 168,121 $ 270,196 Adjustments to reconcile increase in net assets to net cash provided by operating activities: Change in fair value of interest rate swaps (22,304) (7,158) (5,336) (2,531) (Gain) loss in unconsolidated subsidiaries 116 19,637 445 (3,315) Inherent contribution of acquired entity (31,920) - (60) - Contributions from noncontrolling interests (411) - 159 - Gain on sale of business unit - (25,285) - - # Depreciation and amortization 176,341 171,892 59,127 58,403 Amortization of deferred gain on sale of medical office buildings (571) (635) (169) (206) Loss on extinguishment of debt 1,653 3,547-3,504 Restricted contributions and investment return (4,042) (9,745) (2,516) (7,759) Distributions to noncontrolling interests 88,155 94,926 31,144 30,624 Assets limited as to use (677,569) (510,403) (250,561) (239,038) Net changes in operating assets and liabilities: Patient accounts receivable 4,885 (83,671) (7,474) (35,324) e Other assets 21,241 (84,713) 7,957 (41,705) f Accounts payable, accrued liabilities, and other liabilities (13,950) (16,438) 41,640 18,026 Accrued salaries, wages, and related liabilities 13,129 60,035 68,035 66,104 Estimated third-party payer allowances 11,888 43,514 15,976 12,958 Net cash provided by operating activities 45,944 271,717 126,488 129,937 Investing activities Proceeds from sale of a business unit - 25,763 - - # Acquisiton of subsidiary, net of cash received 9,450 - - - Purchase of property and equipment, net of disposals (132,566) (90,034) (54,286) (46,825) Net cash used in investing activities (123,116) (64,271) (54,286) (46,825) Financing activities Increase in restricted net assets 4,042 9,745 2,516 7,759 Repayments on long-term debt (207,000) (177,654) (3,157) (8,487) Proceeds from issuance of long-term debt 354,208 93,600 110 40 Termination of swaps (15,127) - - - Contributions from noncontrolling interests 411 - (159) - Distributions to noncontrolling interests (88,155) (94,926) (31,144) (30,624) Net cash provided by (used in) financing activities 48,379 (169,235) (31,834) (31,312) (Decrease) increase in cash and cash equivalents (28,793) 38,211 40,368 51,800 Cash and cash equivalents at beginning of period 414,674 415,860 345,513 402,271 Cash and cash equivalents at end of period $ 385,881 $ 454,071 $ 385,881 $ 454,071 15

Notes to Consolidated Financial Statements (Unaudited) 1. Basis of Presentation Indiana University Health, Inc. (Indiana University Health), an Indiana private, nonprofit organization (exempt from federal income taxes as an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986), as amended (the Code), and classified as a public charity under Section 509(a) of the Code, is a health care delivery system that provides services throughout the State of Indiana (the State). Indiana University Health s mission is to improve the health of its patients and the communities it serves through innovation and excellence in care, education, research, and service. The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete, annual financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature. Operating results for the nine months ended September 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018. For further information, refer to the audited consolidated financial statements and notes thereto for the years ended December 31, 2017 and 2016 (not included herein). The accompanying unaudited consolidated financial statements include the accounts of Indiana University Health and all majority-owned or controlled subsidiaries (collectively referred to herein as the Indiana University Health System). The equity method of accounting is used for investments in joint ventures, partnerships, and companies where control is participatory with others or where ownership is 50% or less, but significant influence over the investee is established. All significant intercompany balances and transactions have been eliminated in consolidation. 2. Summary of Significant Accounting Policies Revenue Recognition In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, related to recognizing revenue from contracts with customers. This new guidance dictates that the standard be applied either full retrospective to each prior reporting period presented, or modified retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application. Subsequently, the FASB issued updates to this guidance to provide clarification to the aspects of collectability criterion, identifying performance obligations and the licensing implementation guidance and recognizing revenue when another party is involved in providing goods or services to a customer. As of January 1, 2018, the Indiana University Health System adopted the new standard using a full retrospective approach, as permitted. 16

Notes to Consolidated Financial Statements (Unaudited) 2. Summary of Significant Accounting Policies (continued) As a result of the adoption, the Indiana University Health System no longer presents the provision for uncollectible accounts as a separate line within its consolidated statements of operations and changes in net assets, but rather it includes the amounts within the patient service revenue line. There were no changes to previously reported revenues as a result of the adoption (presentation only). As its performance obligations relate to contracts with a duration of less than one year, the Indiana University Health System has applied the practical expedient, as provided in FASB Accounting Standards Codification (ASC) 606, and is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The unsatisfied or partially unsatisfied performance obligations referred to above are primarily related to inpatient acute care services at the end of the reporting period. The performance obligations for these contracts are generally completed when the patients are discharged, which typically occurs within days or weeks of the end of the reporting period. As provided for under FASB ASC 606, the Indiana University Health System does not adjust the promised amount of consideration from patients and third-party payers for the effects of a significant financing component due to Indiana University Health System s expectation that the period between the time the service is provided to a patient and the time that the patient or a third-party payer pays for that service will be one year or less. However, the Indiana University Health System does, in certain instances, enter into payment agreements with patients that allow payments in excess of one year. For those cases, the financing component is not deemed to be significant to the contract. The Indiana University Health System has applied the practical expedient provided within FASB ASC 340. The Indiana University Health System does not incur significant costs in obtaining contracts with customers (patients). Any costs which are incurred, are expensed in the period of occurrence, as the amortization period of any asset that the Indiana University Health System otherwise would have recognized is one year or less in duration. Patient Service Revenue Revenue is recognized as performance obligations are satisfied. Performance obligations are determined based on the nature of the goods or services provided by the Indiana University Health System. Patient service revenue is recognized at an amount that reflects the consideration to which the Indiana University Health System expects to be entitled in exchange for providing patient care. The amounts recognized reflect variable consideration, such as discounts, contractual allowances, concessions and contingent payments. These amounts 17

Notes to Consolidated Financial Statements (Unaudited) 2. Summary of Significant Accounting Policies (continued) are due from patients, third-party payers (including health insurers and government programs), and others. Performance obligations satisfied over time relate to patients receiving health care services. The Indiana University Health System measures the performance obligation from admission (inpatient) or check-in (outpatient) to the point when it is no longer required to provide services to that patient, which is generally at the time of discharge (inpatient) or check-out (outpatient). Revenue for performance obligations satisfied over time is recognized based on actual charges incurred, in relation to total expected (or actual) charges. This method provides a faithful depiction of the transfer of services over the term of the performance obligation based on the inputs needed to satisfy the obligation. For the periods ended, the Indiana University Health System primarily recognized revenue from services provided over time. The Indiana University Health System determines the transaction price based on standard charges for goods and services provided, reduced by contractual adjustments provided to third-party payers, discounts provided to uninsured patients in accordance with the Indiana University Health System s policy, and/or implicit price concessions provided to uninsured patients. The Indiana University Health System determines its estimates of contractual adjustments and discounts based on contractual agreements, its discount policies, and historical experience. Agreements with third-party payers typically provide for payments at amounts less than established charges. A summary of the payment arrangements with major third-party payers follows: Medicare: Certain inpatient acute care services are paid at prospectively determined rates per discharge based on clinical, diagnostic and other factors. Certain services are paid based on cost-reimbursement methodologies subject to certain limits. Outpatient services are paid using prospectively determined rates. Physician services are paid based upon established fee schedules. Medicaid: Reimbursements for Medicaid services are generally paid at prospectively determined rates per discharge, per occasion of service, or per covered member. Other: Payment agreements with certain commercial insurance carriers, health maintenance organizations, and preferred provider organizations use prospectively determined rates per discharge, discounts from established charges, and prospectively determined daily rates. 18

Notes to Consolidated Financial Statements (Unaudited) 2. Summary of Significant Accounting Policies (continued) Settlements with third-party payers for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payer, correspondence from the payer, and the Indiana University Health System s historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as amounts become known (that is, new information becomes available), as years are settled or years are no longer subject to such audits, reviews, and investigations. Adjustments arising from changes in estimated contractual adjustments were not significant in 2018 or 2017. Generally patients who are covered by third-party payers are responsible for related deductibles and coinsurance, which vary in amount. The Indiana University Health System also provides services to uninsured patients, and offers those uninsured patients a discount, either by policy or law, from standard charges. The Indiana University Health System estimates the transaction price for patients with deductibles and coinsurance and from those who are uninsured based on historical experience and current market conditions. The initial estimate of the transaction price is determined by reducing the standard charge by any contractual adjustments, discounts, and implicit price concessions based on historical collection experience. Subsequent changes to the estimate of the transaction price are generally recorded as adjustments to patient service revenue in the period of the change. The Indiana University Health System determines its estimate of implicit price concessions based on its historical collection experience by class of patients. Consistent with the Indiana University Health System s mission, care is provided to patients regardless of their ability to pay. Therefore, the Indiana University Health System has determined it has provided implicit price concessions to uninsured patients and patients with other uninsured balances (for example, copays and deductibles). The implicit price concessions included in estimating the transaction price represent the difference between amounts billed to patients and the amounts Indiana University Health System expects to collect based on collection history with comparable patients. For the periods ended, additional revenue recognized due to changes in its estimates of implicit price concessions for performance obligations satisfied in prior periods was not significant. Subsequent changes in transaction price that are determined to be the result of an adverse change in the patient s ability to pay are recorded as bad debt expense. Bad debt expense for the periods ended was not significant. 19

Notes to Consolidated Financial Statements (Unaudited) 2. Summary of Significant Accounting Policies (continued) The composition of patient service revenue by payer sources is as follows: Nine Months Ended September 30 2018 2017 Commercial/Managed Care 58% 59% Medicaid 11 10 Medicare 24 23 Self-Pay and Other 7 8 100% 100% One managed care payer represented 32% and 35% of patient service revenue for 2018 and 2017, respectively. Government Programs During 2012, the Indiana General Assembly approved a hospital assessment fee program (Medicaid Assessment Fee). Under this program, the Office of Medicaid Policy and Planning (OMPP) collects a fee from eligible hospitals. The fee is used in part to increase reimbursement to eligible hospitals for services provided in both fee-for-service and managed care programs, and as the state share of Disproportionate Share Hospital (DSH) payments. The program was effective retroactively from July 1, 2011 through June 30, 2013, and was subsequently extended through June 30, 2019. For the periods ended, payments received related to the Medicaid Assessment Fee program were recorded within patient service revenue in the consolidated statement of operations and changes in net assets totaling $307,680 and $209,080, respectively. During the periods ended, assessment fees were recorded within the hospital assessment fee line on the consolidated statements of operations and changes in net assets totaling $109,472 and $97,815, respectively. The Indiana University Health System qualifies for supplemental Medicaid payments through the upper payment limit reimbursement program (UPL) under Indiana law. The UPL program was established to pay qualifying providers the difference between what Medicare would have paid and what Medicaid actually paid. As of September 30, 2018 and 2017, the Indiana University Health System recognized UPL revenue of $37,205 and $68,003, respectively. 20